Post-COVID-19: Clinical Trials

7 trials for Post-COVID-19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 unknown. 3 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Terminated 1
Phase 31Completed 1

Follow Post-COVID-19: new trials by email Literature Review of Post-COVID-19 trials Research Report on Post-COVID-19

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19
Meplazumab for injection, Normal saline - Post-COVID-19
Phase 3CompletedJiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd1212023-03-232024-05-28
Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment
Fampridine SR, Placebo - Working Memory, Post-covid-19
Not applicableTerminatedProf. Dominique de Quervain, MD82022-06-282024-07-18
Cognitive Training and Brain Stimulation in Patients With Post-COVID-19 Cognitive Impairment
Anodal tDCS, Sham tDCS, Intensive cognitive training - COVID-19, Post-COVID-19
Not applicableCompletedUniversity Medicine Greifswald602022-01-052024-12-05
Sleep Characteristics in Post-COVID-19 Patients
Sleep diagnostics - Post-COVID-19
CompletedSchön Klinik Berchtesgadener Land312021-11-252022-11-30
Effects of Post-COVID-19 on Quadriceps Femoral Muscle-tendon Unit
Post-COVID-19, Healthy Participants
UnknownUniversity of Brasilia902021-08-242023-12-05
The Effects of Video-based Yoga Interventions for Patients With Post-corona Virus Disease
Video-based Yoga Exercises - Post-COVID-19
Not applicableCompletedIstinye University852021-03-222022-06-01
Changes in Selected Function- and Participation-related Characteristics in Post-COVID Patients Following Pneumological Phase II Rehabilitation
Multimodal pulmonary rehabilitation - Post-COVID-19
CompletedPensionsversicherungsanstalt7792020-10-012023-03-28

Narrower conditions

COVID-19 (3)  ·  Fatigue (1)  ·  Pain (1)

Broader conditions

Coronaviridae Infections (3)  ·  Coronavirus Infections (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Nidovirales Infections (3)  ·  Pneumonia (3)  ·  Pneumonia, Viral (3)  ·  RNA Virus Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Virus Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Neurologic Manifestations (1)

Interventions

4-Aminopyridine (1)  ·  Autogenic Training (1)  ·  Control Groups (1)  ·  Injections (1)  ·  Saline Solution (1)  ·  Transcranial Direct Current Stimulation (1)  ·  meplazumab (1)

Sponsors

Istinye University (1)  ·  Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd (1)  ·  Pensionsversicherungsanstalt (1)  ·  Prof. Dominique de Quervain, MD (1)  ·  Schön Klinik Berchtesgadener Land (1)  ·  University Medicine Greifswald (1)  ·  University of Brasilia (1)

Countries

Germany (2)  ·  Austria (1)  ·  Brazil (1)  ·  China (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Andreas Papassotiropoulos, Prof. MD (1)  ·  David Felder, Mag. (1)  ·  Dominique de Quervain, Prof. MD (1)

Results publications

PMID 35410927, PMID 40991619, PMID 42300213, PMID 42369154